SCHEMBL5508094

SCHEMBL5508094

COCCc1nc2c(N)nc3cccc(CCCN)c3c2[nH]1

nearest known ligand 0.41

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
TLR8 Q9NR97 11/20 0.41
CSNK1A1 P48729 1/20 0.36
CSNK1D P48730 1/20 0.36
PRKCD Q05655 1/20 0.36
PAK1 Q13153 1/20 0.36
CAMK2B Q13554 1/20 0.36
CAMK2G Q13555 1/20 0.36
CAMK2D Q13557 1/20 0.36
TAOK1 Q7L7X3 1/20 0.36
DHFR P00374 5/20 0.34
DCPS Q96C86 2/20 0.32
CACNA1H O95180 1/20 0.32
MMP13 P45452 1/20 0.31
TLR7 Q9NYK1 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5504623 0.99 TLR8 (0.40) TLR8CSNK1A1CSNK1DPRKCDPAK1
SCHEMBL5276268 0.97 TLR8 (0.42) TLR8CSNK1A1CSNK1DPRKCDPAK1
SCHEMBL18587589 0.88 TLR8 (0.48) TLR8CSNK1A1CSNK1DPRKCDPAK1
SCHEMBL5271662 0.87 TLR8 (0.43) TLR8CSNK1A1CSNK1DPRKCDPAK1
SCHEMBL18587553 0.87 TLR8 (0.50) TLR8CSNK1A1CSNK1DPRKCDPAK1
SCHEMBL18587595 0.86 TLR8 (0.46) TLR8CSNK1A1CSNK1DPRKCDPAK1
SCHEMBL18588106 0.84 TLR8 (0.42) TLR8CSNK1A1CSNK1DPRKCDPAK1
SCHEMBL18585619 0.83 TLR8 (0.52) TLR8TLR7
SCHEMBL18587114 0.83 TLR8 (0.46) TLR8CSNK1A1CSNK1DPRKCDPAK1
SCHEMBL5075205 0.79 TLR8 (0.43) TLR8CSNK1A1CSNK1DPRKCDPAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1850849-A2 METHOD OF PREFERENTIALLY INDUCING THE BIOSYNTHESIS OF INTERFERON Coley Pharmaceutical Group, Inc. (US) 2007-11-07 EP disclosed
WO-2006091647-A2 METHOD OF PREFERENTIALLY INDUCING THE BIOSYNTHESIS OF INTERFERON COLEY PHARMACEUTICAL GROUP, INC. (US) 2006-08-31 WO disclosed